Moreover, Le-Le Zhang et al. [29] recruited and randomized into two groups (i.e., [68Ga]PSMA-11 PET/CT and TRUS) a total of 120 patients with PSA levels > 4 ng/mL for the diagnosis of PCa, in particular, csPCa. This evidence concerns the gene KLK3 and posterior cortical atrophy.